Main Project Partners  Project Title  Award Date Value

Mikata Health Inc.,
Kyle Nishiyama

AI for improved physician efficiency and patient care: Real-world implementation of leading models, privacy, safety and data integration.

March 15, 2024 $800,000

University of Alberta,
Luke Eckersley

SCANAID – Screening Congenital Heart Anomalies using Artificial Intelligence Detection.

March 15, 2024 $798,857

University of Alberta,
Gregory Kawchuk

An agile AI pipeline for urgent health conditions requiring diagnostic imaging.

March 15, 2024 $799,662

University of Alberta,
Mi-Young Kim

Developing AI to support timely and informed suggestion-making for Alberta Health Link 811.

March 15, 2024 $783,988

University of Alberta,
Bo (Cloud) Cao

Evaluation of AI-enabled opioid overdose prediction: from research to real-world.

March 15, 2024 $800,000

University of Alberta,
Osmar Zaaine

Empowering Navigation and Access to Mental Health Service and Programs: The MIRA Artificial Intelligence Informational Chatbot.

March 15, 2024 $799,447

University of Calgary,
Aravind Ganesh

AI-guided identification and auditing of treatment-eligible ischemic strokes in Alberta.

March 15, 2024 $800,000

University of Calgary,
Ian Lewis

Stopping hospital-transmitted infection outbreaks by equipping infection prevention and control teams with automated AI-enabled genomic analysis technology.

March 15, 2024 $799,989

University of Calgary,
Kerry McBrien

Digital Health Tools & Artificial Intelligence for Understanding and Addressing Social Determinants of Health in Primary Care.

March 15, 2024 $755,500

University of Calgary,
Aaron Phillips

AI-Enabled Individualized Health Risk Prediction for Spinal Cord Injury and Beyond. March 15, 2024 $800,000

University of Calgary,
James White

A Scalable Digital Health Platform for the Ethical and Equitable Implementation of Artificial Intelligence Clinical Decision Support. March 15, 2024 $795,625

Symbiotic AI,
Joonwu Lee

Towards implementation and adoption of an AI-based decision support tool for patients with coronary artery disease in real-world clinical settings. March 15, 2024 $799,969